Bone Therapeutics to Strategically Focus on ALLOB Cell Therapy
ALLOB is the company's most advanced clinical asset. The product is currently engaged in a Phase IIb study to treat...
ALLOB is the company's most advanced clinical asset. The product is currently engaged in a Phase IIb study to treat...
BIOSPHERE FLEX SP Extremities is a sheet putty comprising spherical bioactive glass granules plus a porous collagen/sodium hyaluronate carrier....
BIOSPHERE MIS II uses a pre-loaded bone graft cannula and a streamlined trigger-based system as a bone graft delivery solution....
The ASPIRE study is intended to evaluate use of P-15L Bone Graft in TLIF in 290 patients with degenerative disc...
Orthofix Medical commenced full market launch of Opusâ„¢ BA, a synthetic bioactive bone graft solution for cervical and lumbar spine...
This is the second Breakthrough Designation for Theradaptive in spinal fusion, granted for the OsteoAdapt SP implant....
Proposed indications include filling of bony voids and gaps, and protecting against microbial colonization while granules resorb and are replaced...
A critical component for bone development, magnesium contains high strength and a modulus of elasticity that closely resembles human bone....
This is the second-ever bone graft to achieve clearance for standalone use in the spine based on human clinical data....
Results address bone formation properties of a clinically accepted bone graft material, bioactive glass, and its optimization....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.